Back

Circulating interleukin-8 levels are associated with myocardial injury, left ventricular function and future clinical adverse events in patients with ST-elevation myocardial infarction.

29 August 2017 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: CAD: role of inflammation and immunity Inflammation and microcirculation ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Christian Shetelig

Oslo University Hospital Ulleval, Oslo (Norway)

6 More presentations in this session

Presentation thumbnail
Infarct size in a rat model of STEMI is reduced by interleukin-6 trans-signalling blockade using sgp130fc but not an anti-IL6R monoclonal antibody
Doctor M. George (London, GB)
Abstract Slides
Presentation thumbnail
Impact of LR11 as residual risk on long term clinical outcomes in patients with coronary artery disease treated with statin after first percutaneous coronary intervention
Doctor N. Takahashi (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Activation of regulatory T cells in patients with myocardial infarction endows them with enhanced suppressive ability and pro-inflammatory phenotype and function
Associate Professor I. Dumitriu (Birmingham, GB)
Abstract
Presentation thumbnail
Inflammasome induced endothelial microparticles impair cellular function in human coronary arterial smooth muscle cells.
Mr A. Ackerschott (Bonn, DE)
Abstract Slides
Presentation thumbnail
Markers of gut leakage are associated with cardiovascular events in a high-risk population
Doctor A. Awoyemi (Oslo, NO)
Abstract Slides

Access the full session

Session thumbnail
CAD: role of inflammation and immunity

The Event

Event poster

ESC Congress 2017

29 August 2017 10:05 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources